<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Amyloid-beta clearance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/amyloid-beta-clearance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 10 Oct 2025 09:42:56 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Amyloid-beta clearance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Neprilysin Gene Transfer Lowers Abeta, Boosts Behavior</title>
		<link>https://bioengineer.org/neprilysin-gene-transfer-lowers-abeta-boosts-behavior/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 10 Oct 2025 09:42:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alzheimer's disease treatment]]></category>
		<category><![CDATA[Amyloid-beta clearance]]></category>
		<category><![CDATA[APP transgenic mice]]></category>
		<category><![CDATA[Neprilysin gene transfer]]></category>
		<category><![CDATA[Neurodegenerative gene therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/neprilysin-gene-transfer-lowers-abeta-boosts-behavior/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Neuroscience, researchers have explored the potential of long-term neprilysin gene transfer as a therapeutic strategy in Alzheimer’s disease. The focus of this research lies in the transgenic mouse model that expresses human amyloid precursor protein (APP), which is pivotal for understanding the mechanisms behind amyloid-beta (Abeta) accumulation in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">278567</post-id>	</item>
	</channel>
</rss>
